Saamir A Hassan1, Nicolas L Palaskas2, Ali M Agha2, Cezar Iliescu2, Juan Lopez-Mattei2, Christopher Chen3, Henry Zheng3, Syed Wamique Yusuf2. 1. Department of Cardiology, Division of Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. sahassan1@mdanderson.org. 2. Department of Cardiology, Division of Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 3. Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
Abstract
PURPOSE OF REVIEW: Carcinoid heart disease is a rare disorder that is associated with significant morbidity and mortality. In this review of the literature, we will present current concepts in diagnosis and management of carcinoid heart disease. RECENT FINDINGS: Recent expert consensus guidelines highlight the role of echocardiography and screening with NT-proBNP for the evaluation of carcinoid heart disease. Advances in medical therapy along with better surgical outcomes highlight the experience and expertise that has been gained in the treatment of carcinoid heart disease. Carcinoid heart disease occurs in patients with neuroendocrine tumors who have carcinoid syndrome. Serotonin appears to play a central role in the development of carcinoid heart disease. Cardiac biomarkers and multimodality imaging can be used to aid in screening and diagnosis. The mainstay of treatment of carcinoid heart disease is surgery.
PURPOSE OF REVIEW: Carcinoid heart disease is a rare disorder that is associated with significant morbidity and mortality. In this review of the literature, we will present current concepts in diagnosis and management of carcinoid heart disease. RECENT FINDINGS: Recent expert consensus guidelines highlight the role of echocardiography and screening with NT-proBNP for the evaluation of carcinoid heart disease. Advances in medical therapy along with better surgical outcomes highlight the experience and expertise that has been gained in the treatment of carcinoid heart disease. Carcinoid heart disease occurs in patients with neuroendocrine tumors who have carcinoid syndrome. Serotonin appears to play a central role in the development of carcinoid heart disease. Cardiac biomarkers and multimodality imaging can be used to aid in screening and diagnosis. The mainstay of treatment of carcinoid heart disease is surgery.
Authors: M E Caplin; E Baudin; P Ferolla; P Filosso; M Garcia-Yuste; E Lim; K Oberg; G Pelosi; A Perren; R E Rossi; W D Travis Journal: Ann Oncol Date: 2015-02-02 Impact factor: 32.976
Authors: P A Robiolio; V H Rigolin; J K Harrison; J E Lowe; J O Moore; T M Bashore; J M Feldman Journal: Am J Cardiol Date: 1995-03-01 Impact factor: 2.778
Authors: Saamir A Hassan; Jose Banchs; Cezar Iliescu; Arvind Dasari; Juan Lopez-Mattei; Syed Wamique Yusuf Journal: Heart Date: 2017-06-08 Impact factor: 5.994
Authors: Utpal H Pandya; Patricia A Pellikka; Maurice Enriquez-Sarano; William D Edwards; Hartzell V Schaff; Heidi M Connolly Journal: J Am Coll Cardiol Date: 2002-10-02 Impact factor: 24.094
Authors: David L Bushnell; Thomas M O'Dorisio; M Sue O'Dorisio; Yusuf Menda; Rodney J Hicks; Eric Van Cutsem; Jean-Louis Baulieu; Francoise Borson-Chazot; Lowell Anthony; Al B Benson; Kjell Oberg; Ashley B Grossman; Mary Connolly; Hakim Bouterfa; Yong Li; Katherine A Kacena; Norman LaFrance; Stanislas A Pauwels Journal: J Clin Oncol Date: 2010-03-01 Impact factor: 44.544
Authors: James C Yao; Nicola Fazio; Simron Singh; Roberto Buzzoni; Carlo Carnaghi; Edward Wolin; Jiri Tomasek; Markus Raderer; Harald Lahner; Maurizio Voi; Lida Bubuteishvili Pacaud; Nicolas Rouyrre; Carolin Sachs; Juan W Valle; Gianfranco Delle Fave; Eric Van Cutsem; Margot Tesselaar; Yasuhiro Shimada; Do-Youn Oh; Jonathan Strosberg; Matthew H Kulke; Marianne E Pavel Journal: Lancet Date: 2015-12-17 Impact factor: 79.321
Authors: Ali M Agha; Juan Lopez-Mattei; Teodora Donisan; Dinu Balanescu; Cezar A Iliescu; Jose Banchs; Peter Y Kim; Nicolas L Palaskas; Syed Yusuf; Greg Gladish; Saamir Hassan Journal: Open Heart Date: 2019-06-04
Authors: Bala Pushparaji; Teodora Donisan; Dinu V Balanescu; Nicolas Palaskas; Peter Kim; Juan Lopez-Mattei; Mehmet Cilingiroglu; Saamir A Hassan; Konstantinos Dean Boudoulas; Konstantinos Marmagkiolis; Ludhmila Abrahao Hajjar; Cezar A Iliescu Journal: Curr Oncol Rep Date: 2021-09-27 Impact factor: 5.075
Authors: Juan C Lopez-Mattei; Eric H Yang; Maros Ferencik; Lauren A Baldassarre; Susan Dent; Matthew J Budoff Journal: JACC CardioOncol Date: 2021-12-21